Tagrisso: kurapa kenza yemapapu
Zvemukati
Tagrisso mushonga unorwisa kenza uyo unoshandiswa kurapa isiri-diki kenza yemapapu kenza.
Mushonga uyu une Osimertinib, chinhu chinodzivirira mashandiro eEGFR, kenza cell receptor inodzora kukura kwayo uye kuwanda. Nekudaro, mamota maseru haakwanise kukura mushe uye kumhanyisa kwekenza kukura kunodzikira, kunatsiridza mhedzisiro yemamwe marapirwo, senge chemotherapy.
Tagrisso inogadzirwa nemalabhoritari eAstraZeneca uye inogona kutengwa mumafamasi ane mushonga, mune 40 kana 80 mg mapiritsi.
Mutengo
Kunyangwe ichi chinwiwa chakatobvumidzwa neAnvisa muBrazil, hachisati chiri kutengeswa.
Chii ichochi
Tagrisso inoratidzirwa kurapwa kwevakuru vane yemuno epamberi isiri-diki sero kenza yemapapu kana metastases ine yakanaka T790M mutation mune EGFR receptor gene.
Kushandisa sei
Kurapa nemushonga uyu kunofanirwa kugara kuchitungamirwa neye oncologist, zvinoenderana nedanho rekuvandudza gomarara.
Nekudaro, iyo inokurudzirwa dosi ndeye 1 80 mg piritsi kana 2 40 mg piritsi kamwe pazuva.
Zvinogona kuitika mhedzisiro
Iko kushandiswa kweTagrisso kunogona kukonzera mimwe mhedzisiro senge manyoka, kurwadziwa nemudumbu, mikoko uye ganda rinopenya uye shanduko mukuyedzwa kweropa, kunyanya muhuwandu hwemaplatelet, leukocyte uye neutrophils.
Ndiani asingafanire kushandisa
Tagrisso haifanire kushandiswa nevakadzi vane nhumbu kana vanoyamwisa, pamwe nevanhu vane allergiki kune chero chinhu chemufomula. Uye zvakare, haufanire kutora wort St. John panguva yekurapwa nemushonga uyu.